Evidence map›Paper›PMID 39348626›Full record

ArticleJCO global oncology2024

Registry of Genetic Alterations of Taiwan Non-Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521.

Bin-Chi Liao, Nai-Jung Chiang, Gee-Chen Chang, Wu-Chou Su, Yung-Hung Luo, Inn-Wen Chong, Tsung-Ying Yang, Chun-Liang Lai, Te-Chun Hsia, Ching-Liang Ho and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in JCO global oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Observational
  2. Sex, hormones, and lung health.Physiological reviews · 2026
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Bin-Chi LiaoDepartment of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.ORCID 0000-0002-7092-0764
Nai-Jung ChiangDepartment of Oncology, Taipei Veterans General Hospital, Taipei, Taiwan.
Gee-Chen ChangSchool of Medicine and Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
Wu-Chou SuDepartment of Oncology, National Cheng Kung University Hospital, Tainan, Taiwan.
Yung-Hung LuoDepartment of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.ORCID 0000-0002-4194-162X
Inn-Wen ChongDivision of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.ORCID 0000-0001-8328-8684
Tsung-Ying YangDivision of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
Chun-Liang LaiDivision of Pulmonology and Critical Care, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan.ORCID 0000-0002-4705-1919
Te-Chun HsiaSection of Pulmonary and Critical Care, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan.
Ching-Liang HoDivision of Hematology/Oncology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.ORCID 0000-0002-8378-1687
Kang-Yun LeeTaipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan.
Chin-Fu HsiaoInstitute of Population Health Sciences, National Health Research Institutes, Miaoli, Taiwan.
Fan-Chen KuNovartis (Taiwan) Co, Ltd, Taipei, Taiwan.
Wei-Tse FangPfizer Ltd, Taipei, Taiwan.ORCID 0009-0008-1730-6942
James Chih-Hsin YangDepartment of Medical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.ORCID 0000-0002-5586-5138

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTissue-based next-generation sequencing (NGS) analysis is highly recommended for patients with advanced/metastatic non-small cell lung cancer (NSCLC). We investigated a specific patient population with NSCLC that required tissue-based NGS analysis. MATERIALS AND

methodsWe enrolled 500 patients with advanced/metastatic (1) epidermal growth factor receptor (

resultsCohort 1: EGFR TKI-pretreated

conclusionThis multicenter registration study investigated tissue-based NGS for a specific patient population with NSCLC in Taiwan.

Indexed as

Carcinoma, Non-Small-Cell LungHigh-Throughput Nucleotide SequencingLung NeoplasmsMutationAdultAgedAged, 80 and overAnaplastic Lymphoma KinaseCohort StudiesErbB ReceptorsFemaleHumansMaleMiddle AgedProtein Kinase InhibitorsRegistriesAnaplastic Lymphoma KinaseEGFR protein, humanErbB ReceptorsProtein Kinase Inhibitors

Identifiers

PMID39348626
PMCPMC11457298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.